Furthermore, the peptide αCT1, which selectively inhibits Cx43 hemichannel activity, has been shown to enhance the sensitivity of glioma cells to chemotherapy, featuring a potential therapeutic strategy to improve the efficacy of chemotherapy in gliomas [74]. The gene discussed is TRAF3IP2; the disease is glioma.